Adult Patients Who Have Relapsed or Refractory CLL (3rd Line) or SLL

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB13881Tisagenlecleucel2Completed1